作者
Ti‐Cheng Chang,Wenan Chen,Chunxu Qu,Zhongshan Cheng,Dale J. Hedges,Abdelrahman Elsayed,Stanley Pounds,Mary Shago,Karen R. Rabin,Elizabeth A. Raetz,Meenakshi Devidas,Cheng Cheng,Anne Angiolillo,Pradyuamna Baviskar,Michael J. Borowitz,Michael J. Burke,Andrew J. Carroll,William L. Carroll,I‐Ming Chen,Richard C. Harvey,Nyla A. Heerema,Ilaria Iacobucci,Jeremy Wang,Sima Jeha,Eric Larsen,Leonard A. Mattano,Kelly W. Maloney,Ching‐Hon Pui,Nilsa C. Ramirez,Wanda L. Salzer,Cheryl L. Willman,Naomi Winick,Brent L. Wood,Stephen P. Hunger,Gang Wu,Charles G. Mullighan,Mignon L. Loh
摘要
Although cure rates for childhood acute lymphoblastic leukemia (ALL) exceed 90%, ALL remains a leading cause of cancer death in children. Half of relapses arise in children initially classified with standard-risk (SR) disease.